74 related articles for article (PubMed ID: 20504105)
1. Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
Odabaşi AR; Küçük M; Yüksel H; Güner Z; Sezer SD
Gynecol Endocrinol; 2011 Mar; 27(3):176-9. PubMed ID: 20504105
[TBL] [Abstract][Full Text] [Related]
2. Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Cagnacci A; Tirelli A; Renzi A; Paoletti AM; Volpe A
Contraception; 2006 Apr; 73(4):348-51. PubMed ID: 16531164
[TBL] [Abstract][Full Text] [Related]
3. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
Winkler UH; Ferguson H; Mulders JA
Contraception; 2004 Jun; 69(6):469-76. PubMed ID: 15157791
[TBL] [Abstract][Full Text] [Related]
4. An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
Winkler UH; Röhm P; Höschen K
Contraception; 2010 May; 81(5):391-400. PubMed ID: 20399945
[TBL] [Abstract][Full Text] [Related]
5. Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
Gersten J; Hsieh J; Weiss H; Ricciotti NA
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):635-642. PubMed ID: 27287084
[TBL] [Abstract][Full Text] [Related]
6. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
7. Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Mackie IJ; Piegsa K; Furs SA; Johnson J; Bounds W; Machin SJ; Guillebaud J
Br J Haematol; 2001 Jun; 113(4):898-904. PubMed ID: 11442481
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
9. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
Shoupe D
Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
[TBL] [Abstract][Full Text] [Related]
10. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
Nappi RE; Paoletti AM; Volpe A; Chiovato L; Howard B; Weiss H; Ricciotti N
Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):285-94. PubMed ID: 24923685
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol.
Kroll R; Ackerman R; Feldman R; Howard B; Weiss H; Hsieh J; Ricciotti N
Contraception; 2016 Mar; 93(3):249-56. PubMed ID: 26499407
[TBL] [Abstract][Full Text] [Related]
12. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraceptives and their minor side effects: comparison of three low-dose estroprogestinic combinations].
Perrone G; Calzolari E; Mancone M; Masci A; Steffe M; Tesseri E
Patol Clin Ostet Ginecol; 1987; 15(1):6-11. PubMed ID: 12286707
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
16. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
17. Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 μg compared with a 21/7 regimen of desogestrel 150 μg/ethinylestradiol 20 μg: a pooled analysis.
Anttila L; Neunteufel W; Petraglia F; Marr J; Kunz M
Clin Drug Investig; 2011; 31(8):519-525. PubMed ID: 21721590
[TBL] [Abstract][Full Text] [Related]
18. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
Kluft C; Endrikat J; Mulder SM; Gerlinger C; Heithecker R
Contraception; 2006 Apr; 73(4):336-43. PubMed ID: 16531162
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
20. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
